FDA's Label Directive Pumps Up Plaintiffs In Drug Suits

Law360, New York (February 6, 2013, 9:22 PM EST) -- The U.S. Food and Drug Administration might have unwittingly handed plaintiffs an attractive new weapon in failure-to-warn litigation against drugmakers when it revealed Tuesday that most prescription drugs do not adhere to the format changes laid out in a 2006 labeling rule, attorneys say.

In a notice, the FDA told drugmakers it would help them convert their product labels to the format in the so-called physician labeling rule — a 2006 regulation designed to make drug warnings easier for physicians to read and focus labels on...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.